Both in Pharmaceuticals
Nuvation Bio vs Phibro Animal Health
Over the past year NUVB returned −11.2% and PAHC returned −10.7%; their daily moves had a correlation of 0.08.
NUVB −11.2% PAHC −10.7%Growth of $1, one year, split-adjusted
| Metric | NUVB | PAHC |
|---|---|---|
| Price | $4.66 | $40.10 |
| Market cap | $1.63B | $1.63B |
| Today | −2.21% | +3.14% |
| 1 month | −9.4% | +7.7% |
| 6 months | +5.6% | −26.7% |
| Year to date | −48.0% | +7.3% |
| 1 year | −9.6% | −4.2% |
| Revenue growth (YoY) | +555.6% | +4.8% |
| Gross margin | 73.0% | 33.9% |
| Net margin | −198.3% | 5.5% |
| P/E (TTM) | — | 16.3× |
| Price / sales | 9.6× | 1.1× |
| Net cash | $399.4M | -$650.8M |
| Dividend yield | — | 1.20% |
| Volatility (60d) | 50.5% | 30.1% |
| Short % of float | 23.9% | 4.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).